SU14813 maleate is a multi-targeted receptor tyrosine kinase inhibitor provided for research use. It shows low-nanomolar inhibitory activity against VEGFR2, VEGFR1, PDGFRβ, and KIT, and is supplied as a solid or as a 10 mM solution in DMSO for laboratory studies.
- Multi-target RTK inhibition with low-nanomolar potency.
- Activity data reported for VEGFR2, VEGFR1, PDGFRβ, and KIT.
- Available as solid packs and a 10 mM DMSO solution for easy preparation.
- High reported purity appropriate for in vitro and preclinical research.
- Supplied with SDS documentation for safe laboratory handling.